---
title: "89bio Completes Merger and Delists from Nasdaq"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263536300.md"
description: "89bio has completed its merger, resulting in its delisting from Nasdaq and significant changes in its management structure. The company is now a wholly owned subsidiary of its parent company, with board members resigning. The latest analyst rating for ETNB stock is a Hold with a $14.50 price target. Spark's AI Analyst rates ETNB as Neutral, citing ongoing losses and cash flow issues, despite promising clinical progress. The stock is considered high-risk, high-reward, with a current market cap of $2.2B and an average trading volume of 5,392,262 shares."
datetime: "2025-10-30T13:34:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263536300.md)
  - [en](https://longbridge.com/en/news/263536300.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263536300.md)
---

# 89bio Completes Merger and Delists from Nasdaq

89bio ( (ETNB) ) has issued an update.

On October 30, 2025, 89bio concluded a merger process, resulting in the termination of its Loan and Security Agreement from January 2023. The merger led to the company becoming a wholly owned subsidiary of the Parent company, with significant changes in the company’s stock and management structure, including the delisting of its shares from Nasdaq and the resignation of its board members.

The most recent analyst rating on (ETNB) stock is a Hold with a $14.50 price target. To see the full list of analyst forecasts on 89bio stock, see the ETNB Stock Forecast page.

**Spark’s Take on ETNB Stock**

According to Spark, TipRanks’ AI Analyst, ETNB is a Neutral.

The overall score for 89bio is primarily weighed down by the financial performance due to ongoing losses and cash flow issues. Technical indicators show bearish momentum, adding to the risk. Although corporate events highlight promising clinical progress, the company’s valuation remains low due to negative earnings, typical in the biotech industry. The stock reflects high-risk, high-reward potential.

To see Spark’s full report on ETNB stock, click here.

**More about 89bio**

**Average Trading Volume:** 5,392,262

**Technical Sentiment Signal:** Buy

**Current Market Cap:** $2.2B

Find detailed analytics on ETNB stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [ETNB.US](https://longbridge.com/en/quote/ETNB.US.md)